Matinas BioPharma
(NYSEMKT) MTNB
Matinas BioPharma Financials at a Glance
Market Cap
$3.50M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.96M
EPS (TTM)
$-2.05
P/E Ratio
-0.27
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$0.52
Volume
0
Open
$0.52
Price
$0.52
Volume
0
Open
$0.52
Previous Close
$0.52
Daily Range
$0.52 - $0.52
52-Week Range
$0.47 - $3.09
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$0.52
Volume
0
Open
$0.52
Previous Close
$0.52
Daily Range
$0.52 - $0.52
52-Week Range
$0.47 - $3.09
MTNB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Matinas BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Jerome D. Jabbour
Website
www.matinasbiopharma.comHeadquarters
Bedminster, NJ 07921, US
MTNB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-177%
Return on Capital
-1%
Return on Assets
-2%
Earnings Yield
-3.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.50M
Shares Outstanding
6.41M
Volume
0
Short Interest
0.00%
Avg. Volume
28.86K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$6.96M
EBITDA
$6.96M
Operating Cash Flow
$7.01M
Capital Expenditure
$0.00
Free Cash Flow
$7.01M
Cash & ST Invst.
$4.00M
Total Debt
$1.35M
Matinas BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$85.00K
+103.6%
Gross Margin
0.00%
N/A
Market Cap
$3.50M
N/A
Market Cap/Employee
$1.17M
N/A
Employees
3
N/A
Net Income
$1.91M
+77.3%
EBITDA
$1.17M
+70.4%
Quarterly Fundamentals
Net Cash
$2.65M
-39.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$658.00K
-69.1%
Short Term Debt
$696.00K
-9.1%
Return on Assets
-1.52%
N/A
Return on Invested Capital
-1.21%
N/A
Free Cash Flow
$1.51M
+57.0%
Operating Cash Flow
$1.51M
+57.0%